Svas Biosana S.p.A. (BIT:SVS)

Svas Biosana Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	24.05	33.4	34.25	21.63	30.44
Short-Term Investments	13.42	4	5.75	7.9	0.62
Cash & Short-Term Investments	37.47	37.39	40	29.53	31.06
Cash Growth	0.21%	-6.53%	35.49%	-4.94%	330.33%
Accounts Receivable	51.14	46.08	41.37	39	31.83
Other Receivables	5.62	4.8	7.85	4.73	3.66
Receivables	56.76	50.88	49.21	43.73	35.49
Inventory	39.85	33.97	32.66	29.82	25.13
Total Current Assets	134.98	123.15	122.73	103.82	92.33
Property, Plant & Equipment	27.68	27.11	26.77	26.21	25.64
Long-Term Investments	0.1	0.17	0.17	0.29	0.22
Goodwill	6.13	0.4	0.68	0.96	1.05
Other Intangible Assets	11.76	11.11	9.88	8.77	7.97
Long-Term Deferred Tax Assets	-	0.01	0.01	-	-
Long-Term Deferred Charges	0.72	0.43	0.86	1.29	1.73
Other Long-Term Assets	3.52	3.17	4.5	4.89	6.95
Total Assets	184.91	165.55	165.6	146.23	135.89

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	32.43	28.85	31	28.2	23.34
Accrued Expenses	3.14	3.12	3.99	3.91	3.41
Current Portion of Long-Term Debt	35.18	27.5	27.28	22.88	21.23
Current Income Taxes Payable	0.06	0.07	0.11	0.17	0.05
Other Current Liabilities	3.33	2.78	2.42	2.17	1.68
Total Current Liabilities	74.15	62.31	64.81	57.33	49.7
Long-Term Debt	41.22	38.47	39.9	32.38	33.11
Other Long-Term Liabilities	2.01	1.92	1.9	2	2.11
Total Liabilities	117.38	102.7	106.61	91.72	84.92

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	20.6	20.6	20.6	20.6	20.6
Additional Paid-In Capital	18.18	18.18	18.18	18.18	18.18
Retained Earnings	30.09	24.65	20.36	15.27	11.75
Treasury Stock	-4.03	-3.23	-2.92	-2.48	-2
Comprehensive Income & Other	2.55	2.63	2.77	2.93	2.43
Total Common Equity	67.39	62.83	58.98	54.5	50.96
Minority Interest	0.14	0.01	0.01	0.01	0
Shareholders' Equity	67.53	62.84	58.99	54.51	50.97
Total Liabilities & Equity	184.91	165.55	165.6	146.23	135.89

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	76.41	65.97	67.18	55.26	54.34
Net Cash (Debt)	-38.93	-28.58	-27.18	-25.74	-23.28
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-7.44	-5.36	-	-4.75	-
Filing Date Shares Outstanding	5.22	5.31	-	5.41	-
Total Common Shares Outstanding	5.24	5.33	-	5.42	-
Working Capital	60.83	60.83	57.92	46.48	42.63
Book Value Per Share	12.87	11.79	-	10.06	-
Tangible Book Value	49.49	51.32	48.42	44.77	41.94
Tangible Book Value Per Share	9.45	9.63	-	8.26	-
Land	-	-	-	-	5.76
Machinery	-	-	-	-	52.17
Construction In Progress	-	-	-	-	3.05

Data Source: S&P Global Market Intelligence Last updated: May 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 4, 2026

Data Sources Report a data error